Transcription of CONSTITUTIONAL COURT OF SOUTH AFRICA - …
{{id}} {{{paragraph}}}
CONSTITUTIONAL COURT OF SOUTH AFRICA Case CCT 201/14 In the matter between: PRESIDENT OF THE REPUBLIC OF SOUTH AFRICA First Applicant MINISTER IN THE PRESIDENCY Second Applicant DIRECTOR-GENERAL IN THE PRESIDENCY Third Applicant MINISTER OF HEALTH Fourth Applicant DIRECTOR-GENERAL OF THE DEPARTMENT OF HEALTH Fifth Applicant and SOUTH AFRICAN DENTAL ASSOCIATION First Respondent HOSPITAL ASSOCIATION OF SOUTH AFRICA Second Respondent Neutral citation: President of the Republic of SOUTH AFRICA and Others v SOUTH African Dental Association and Another [2015] ZACC 2 Coram: Mogoeng CJ, Moseneke DCJ, Cameron J, Froneman J, Khampepe J, Leeuw AJ, Madlanga J, Nkabinde J, Tshiqi AJ, Van der Westhuizen J and Zondo J Decided on: 27 January 2015 Summary: Section 167(6) of the Constitution direct access application to declare invalid and set aside President s Proclamation review of exercise of public power 2 National Health Act 61 of 2003 sections 36 to 40 decision to bring provisions into operation premature rationality review ORDER On application for direct access: 1.
CONSTITUTIONAL COURT OF SOUTH AFRICA Case CCT 201/14 In the matter between: PRESIDENT OF THE REPUBLIC OF SOUTH AFRICA First Applicant MINISTER IN THE PRESIDENCY Second Applicant DIRECTOR-GENERAL IN THE PRESIDENCY Third Applicant MINISTER OF HEALTH Fourth Applicant DIRECTOR …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Pharmaceutical Manufacturers Association of, Of south, Pharmaceutical manufacturers first appellant association of south, Association, SOUTH AFRICAN MEDICAL DEVICE INDUSTRY, South African Medical Device Industry Association, TRIPS, Pharmaceutical Patents and Access to, South, Analysis Report, Pharmaceutical, Pharmaceutical Serialization: An Implementation, Pharmaceutical Serialization: An Implementation Guide, Pharmaceutical manufacturers, Stability Testing of Pharmaceutical Products, Pharmaceutical policy in China